Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

CVS Health CEO Larry Merlo to step down next year

Stock MarketsNov 06, 2020 11:40AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
2/2 © Reuters. People look at a CVS vending machine in a subway station in New York 2/2

By Manas Mishra and Caroline Humer

(Reuters) - CVS Health Corp (N:CVS) Chief Executive Officer Larry Merlo will retire after a decade-long tenure at the helm of the company during which he led the $69 billion acquisition of one of the oldest U.S. health insurer, Aetna (NYSE:AET).

Karen Lynch, who was with Aetna at the time of the acquisition in 2018, will succeed Merlo in February, CVS said on Friday. Lynch, 57, has been with Aetna for eight years and was previously president of Magellan Health (NASDAQ:MGLN) Services.

The CVS-Aetna merger was sixty-four-year-old Merlo's vision who wanted to bring more medical services and testing into CVS' HealthHub stores nationwide. The leading pharmacy operator aims to have 600 of those stores by the end of the year and 1,500 next year.

"Investors will likely view this transition positively as Karen Lynch is well respected by the investor community," Evercore ISI analysts said in a client note.

Shares of the company, which raised its full-year profit forecast on Friday after beating analysts' estimates for quarterly earnings, rose 4.1%.

The company said it has administered more than 6 million COVID-19 tests since March, and expects to play an "important role" in COVID-19 vaccinations, once vaccines are available; a handful are in late-stage testing.

CVS and rival Walgreens (O:WBA) have partnered with the U.S. government to offer on-site vaccinations for residents of care home and assisted living facilities. CVS is also expected to provide vaccinations in its pharmacies.

In the third quarter, the company saw same-store pharmacy sales rise 6.7%, helping it beat Wall Street estimates for profit.

CVS earned $1.66 per share on an adjusted basis, beating analysts' average estimate of $1.33 per share, according to IBES data from Refinitiv.

CVS raised its 2020 adjusted earnings per share forecast to $7.35 to $7.45 from $7.14 to $7.27 previously.

CVS Health CEO Larry Merlo to step down next year

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email